ProCE Banner Activity

Precision Medicine in Treatment-Naive and Recurrent Ovarian Cancer

Slideset

Slides featuring expert perspectives on caring for ovarian cancer, including recent advances in the frontline setting, strategies for selecting/sequencing appropriate treatments based on patient and disease risk factors, and management of treatment-related adverse events.

Released: June 01, 2023

Share

Provided by

ProCE Banner

Supporters

Supported by educational grants from AstraZeneca, Eisai, GSK, Karyopharm Therapeutics, and Merck Sharp & Dohme Corp.

AstraZeneca

Eisai

GSK

Karyopharm Therapeutics

Merck Sharp & Dohme Corp.